Lian Brian

President & CEO

Lian Brian has filed 3 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jul 30, 2026.

On the most recent filing, Lian Brian is listed as President & CEO at Viking Therapeutics, Inc. Inside the rolling window, Lian Brian reported no open-market purchases and 2 open-market sales totaling $12.6M in VKTX. The largest disclosed transaction in the window is a sale of 233,409 VKTX shares on Jan 5, 2026, worth $7.7M.

Companies traded

Other insiders at VKTX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$12.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
VKTXSale$4.9MJul 30SEC ↗
VKTXSale$7.7MJan 5SEC ↗
Showing 1–2 of 2
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 28, 2025VKTXSale$1.4M
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Lian Brian made?

Lian Brian has filed 3 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does Lian Brian trade?

Lian Brian has filed SEC Form 4 disclosures for 1 company, including VKTX.

When was Lian Brian's most recent SEC Form 4 filing?

Lian Brian's most recent SEC Form 4 filing on Tracefour is dated Jul 30, 2026.

What is Lian Brian's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Lian Brian is listed as President & CEO.

What is Lian Brian's total buy and sell value in the current window?

Inside the rolling retention window, Lian Brian bought $0 and sold $12.6M based on SEC Form 4 filings.

What was Lian Brian's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 233,409 VKTX shares on 2026-01-05, worth $7.7M, per SEC Form 4 filings.